Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 451 - 500 out of 11,277

Document Document Title
WO/2009/087677A1
The present invention relates to an improved process for the preparation of 2, 3, 6, 3', 4'- Penta-O-acetylsucrose 6-PAS), formula (V) and sucralose, formula (I).  
WO/2009/088618A1
A method for the aralkylation of anthracyclins by utilizing an aralkylating agent R3-CH2X (for example, BnBr) in accordance with the reaction pathway describe by the scheme shown in Fig. 1. The present invention recognizes that 4-R1, 3'-...  
WO/2009/080215A1
Suggested are alkylene oxide adducts of oligosaccharides, obtainable in that an aqueous solution of at least one water-soluble oligosaccharide is subjected to alkoxylation within a temperature range of 90 to 160 °C.  
WO/2009/081211A3
A process of obtaining a saponin-rich component from a plant of the Araliaceae family, the process comprising the steps of: (a) treating a portion of the plant with an extraction solvent in which saponin-containing compounds are soluble;...  
WO/2009/081211A2
A process of obtaining a saponin-rich component from a plant of the Araliaceae family, the process comprising the steps of: (a) treating a portion of the plant with an extraction solvent in which saponin-containing compounds are soluble;...  
WO/2009/078462A1
Disclosed is a sugar chain primer represented by the following general formula (I). Lac-O-Ck:m(n) (I) (In the formula (I), Ck represents an alkenyl chain; m represents the total number of double bonds; and n represents the positions of t...  
WO/2009/075186A1
Disclosed is a method for producing a 4-deoxy-4-fluoro-D-glucose derivative, wherein a D-galactose derivative is reacted with sulfuryl fluoride (SO2F2), trifluoromethanesulfonyl fluoride (CF3SO2F) or perfluorobutanesulfonyl fluoride (C4F...  
WO/2009/068531A3
The present invention relates to a compound The instant invention relates to a compound of formulae (I A), (I B), (X A), (X B), (Y A) or (Y B), wherein R' represents (formula) and R' represents hydrogen, hydroxy, C1-C7alkoxy, C1-C8-alkan...  
WO/2009/069668A1
Disclosed is a means which is effective for the treatment of melanoma. Specifically disclosed is an agent for increasing the expression of a malignant melanoma antigen, which comprises a compound selected from the group consisting of met...  
WO/2009/067846A1
The invention discloses a purifying method of monoglycoside acid which comprises selective oxidizing primary hydroxy group of the monoglycoside, exchanging the reacted composite liquid through an activated strong acid cation exchange res...  
WO/2009/069800A1
Disclosed are a novel aminoglycoside antibiotic, a production method thereof, and a pharmaceutical use thereof. Specifically disclosed are a compound represented by the formula (I) below, a production method thereof, and a use thereof as...  
WO/2009/066117A1
The invention relates to the use of ethylenediamine tetraacetic acid (EDTA) and its derivatives, i.e. its salts and complexes for prevention and treatment of bacterial intestinal diseases of pigs and for increasing the effects of antibio...  
WO/2009/067692A1
Compounds of structure (I): having antibacterial activity are disclosed, including stereoisomers, pharmaceutically acceptable salts and prodrugs thereof, wherein Q1, Q2, Q3, R8 and R9 are as defined herein. Methods associated with prepar...  
WO/2009/059945A2
1,2-Dideoxy-1,2-diamino oligosaccharides and polysaccharides as shown in General Formula (1) and derivatives thereof are described, and methods suitable for their preparation in free-base, salt or metal-complexed form. In addition, new u...  
WO/2009/059945A3
1,2-Dideoxy-1,2-diamino oligosaccharides and polysaccharides as shown in General Formula (1) and derivatives thereof are described, and methods suitable for their preparation in free-base, salt or metal-complexed form. In addition, new u...  
WO/2009/060086A2
The present invention relates to compounds consisting of glycolipids covalently bound to an antigen or a drug via a linker. The said compounds are able to induce a stronger immune response than a composition comprising separated glycolip...  
WO/2009/060305A3
The invention provides analogs of alpha-galactosyl ceramide that increase the immune response elicited by various antigens. It also provides methods of using such compounds to increase the effectiveness of vaccines.  
WO/2009/060086A3
The present invention relates to compounds consisting of glycolipids covalently bound to an antigen or a drug via a linker. The said compounds are able to induce a stronger immune response than a composition comprising separated glycolip...  
WO/2009/055677A1
Synthetically-derived S,S-heterodisubstituted disulfides that exhibit potent in vitro antibacterial activity against a variety of bacteria, including Staphylococcus aureus, methicillin-resistant Staphylococcus aureus and Francisella tula...  
WO/2009/049428A1
Particular naturally occurring glycosylated acyl-flavonols, e.g. montbretm A (of the formula below wherein R1, R2, R3, R5, R5', and R7 is OH each, X is β-D-glucopyranosyl), are now shown to be effective mammalian α-amylase inhibitors S...  
WO/2009/049370A1
The invention relates to novel compounds that have utility as inhibitors of heparan sulfate-binding proteins; compositions comprising the compounds, and use of the compounds and compositions thereof for the antiangiogenic, antimetastatic...  
WO/2009/052088A2
Fire extinguishing compositions and methods of extinguishing a fire comprising compounds of formula (I) where Rf is a fluorocarbon group. The compounds and compositions described herein are useful as intermediates in the preparation of o...  
WO/2009/048343A1
The invention relates to methods for effecting qualitative and quantitative changes in the functional moieties expressed at the surface of cells and multi-cellular structures, and functional lipid constructs for use in such methods. In p...  
WO/2009/047792A2
The invention provides carbohydrate based compounds of formula (I), methods of preparation, and compositions useful for modulating signaling through Toll -like receptors. The methods involve contacting a TLR -express ing cell with a carb...  
WO/2009/047792A3
The invention provides carbohydrate based compounds of formula (I), methods of preparation, and compositions useful for modulating signaling through Toll -like receptors. The methods involve contacting a TLR -express ing cell with a carb...  
WO/2009/044886A1
The invention aims to provide a process for producing 1,2,3-tri-O-acetyl-5-deoxyribofuranose by an industrially suitable means. The invention provides a process for the production of 1,2,3-tri-O-acetyl-5-deoxyribofuranse which comprises ...  
WO/2009/038978A2
Steviol glycoside isomers are provided having the formula (II): wherein R1may be hydrogen, 1-β-D-glucopyranosyl, or 2-(1-β-D-glucopyranosyl)-1-β-D- glucopyranosyl, and R2 may be hydrogen, 1-β-D-glucopyranosyl, 2-(1-β-D-glucopyranosy...  
WO/2009/036754A1
The invention relates to a composition having the general structure (formula), wherein R1 is a hydrophobic group, R2 is hydrogen (H), a cation or an alkyl ester, R3 is hydrogen (H) or a group that can be converted into the hydroxy group ...  
WO/2009/038978A3
Steviol glycoside isomers are provided having the formula (II): wherein R1may be hydrogen, 1-β-D-glucopyranosyl, or 2-(1-β-D-glucopyranosyl)-1-β-D- glucopyranosyl, and R2 may be hydrogen, 1-β-D-glucopyranosyl, 2-(1-β-D-glucopyranosy...  
WO/2009/035107A1
Disclosed is a transformant produced by introducing a keto reductase gene involved in the biosynthesis of L-epivancosamine into a ray fungus originally capable of producing daunorubicin. Also disclosed is a method for efficiently produci...  
WO/2009/030073A1
Provided is a dTDP-β-D-fucofuranose, which is also referred to as dTDP-β-6-deoxy-D-galactofuranose. The dTDP-β-D-fucofuranose is synthesized by using reductase Fcf1 and mutase Fcf2 in the gram-negative bacteria. Also provided are the ...  
WO/2009/016647A1
The present invention provides novel pyrrolo[2,1-c][1, 4]benzodiazepine- glycoside prodrug of general formula (1a-b), useful as selective anticancer agents. The present invention also provides a process for the preparation of novel pyrro...  
WO/2009/014101A1
Disclosed is a sulfoquinovosyl acyl propanediol derivative represented by the general formula (I) or a pharmaceutically acceptable salt thereof. (I) wherein R1 represents an acyl residue of a fatty acid; and M represents a hydrogen ion o...  
WO/2009/014970A1
Methods of synthesizing sodium glucose co-transporter 2 inhibitors, as well as compounds useful therein, are disclosed. Particular inhibitors are compounds of formula (I).  
WO/2009/004899A1
It is intended to provide a novel sialidase inhibitor capable of inhibiting the activity of sialidase present in Trypanosoma cruzi or the like. An N-acylneuraminic acid derivative in which an aromatic ring has been introduced at the 9-po...  
WO/2009/005129A1
Disclosed are: a non-digestible hydroxypropyl starch hydrolysate which can be used as a novel water-soluble dietary fiber; a method for producing the non-digestible hydroxypropyl starch hydrolysate; and a beverage or food comprising the ...  
WO/2008/151615A2
The invention relates to a method for producing biosurfactants, according to which micro-organisms producing biosurfactants are moved in a nutrient substrate. According to the invention, the nutrient substrate is used in excess and a mec...  
WO/2008/153394A3
The present invention relates to compounds according to formula (I) : wherein R2 is absent or a linking moiety and R3 is selected from the group consisting of anti- inflammatory agents and pharmaceutically acceptable salts thereof, pharm...  
WO/2008/153394A2
The present invention relates to compounds according to formula (I) : wherein R2 is absent or a linking moiety and R3 is selected from the group consisting of anti- inflammatory agents and pharmaceutically acceptable salts thereof, pharm...  
WO/2008/151615A3
The invention relates to a method for producing biosurfactants, according to which micro-organisms producing biosurfactants are moved in a nutrient substrate. According to the invention, the nutrient substrate is used in excess and a mec...  
WO/2008/146917A1
Compounds represented by the general formula (1) [wherein A is aryl; R1 is N-(optionally substituted C1-6 alkyl)-N-(optionally substituted C1-6 alkyl)amino-C1-6 alkyl; R2 is hydrogen or optionally substituted C1-6 alkyl; R3 is optionally...  
WO/2008/146919A1
Disclosed is a compound represented by the formula (I) or a pharmacologically acceptable salt or solvate thereof [in the formula (I), A represents an aryl group and R1 represents a 5- or 6-membered monocyclic heterocyclic group, or A rep...  
WO/2008/147725A1
Exemplary embodiments of this invention encompass a method for purifying a substantially crude stevioside, methods for preparing polymorphic and amorphous forms of stevioside, and the polymorphic and amorphous forms prepared therefrom.  
WO/2008/143677A1
Stable solid, crystalline forms of elsamitrucin salts are provided that are useful in preparing anti-neoplastic parenteral formulations. Also provided are methods for treating neoplastic diseases in humans using parenteral formulations t...  
WO/2008/142155A2
The present invention concerns a method for preparing C-6 phosphorylated D- aldohexoses and C-6 phosphorylated D-aldohexose derivatives, new C-6 phosphorylated D-aldohexoses derivatives and uses thereof. The method comprises incubating p...  
WO/2008/142155A3
The present invention concerns a method for preparing C-6 phosphorylated D- aldohexoses and C-6 phosphorylated D-aldohexose derivatives, new C-6 phosphorylated D-aldohexoses derivatives and uses thereof. The method comprises incubating p...  
WO/2008/134828A8
The present invention provides isolated or essentially pure diterpenoic tetrahydropyran, such as steviol-19-glucuronide, steviol, stevioside and rebaudioside processes for obtaining the same and methods for obtaining stable pharmaceutica...  
WO/2008/134828A3
The present invention provides isolated or essentially pure diterpenoic tetrahydropyran, such as steviol-19-glucuronide, steviol, stevioside and rebaudioside processes for obtaining the same and methods for obtaining stable pharmaceutica...  
WO/2008/137010A1
The present invention relates to dentifrices in general and dentifrices free of chemically-derived foaming agents in particular. Particularly, the present invention relates to an all-natural dentifrice (e.g., toothpaste) comprising a con...  
WO/2008/134828A2
The present invention provides isolated or essentially pure diterpenoic tetrahydropyran, such as steviol-19-glucuronide, steviol, stevioside and rebaudioside processes for obtaining the same and methods for obtaining stable pharmaceutica...  

Matches 451 - 500 out of 11,277